In this study we investigated the effect of local endometrial injury on outcome on IUI cycles. This is a randomized clinical trial being performed at Shiraz Ghadir hospital and private infertility clinics during a 17–months period from January 2011 to May 2012. 144 women with unexplained, mild male factor and mild endometriosis selected for IUI cycles undergoing IUI. Patients were randomly (based on a computer random digit generator using their registration number) assigned to two groups. Group A underwent endometrial biopsy, by a Novak curret biopsy catheter (Neuilly-en-Thelle, France) between days 6–8 of previous menstrual cycle before IUI (n=72) and group B (n=72) underwent IUI cycles without undergoing endometrial biopsy. All the patients received 100-mg per day clomiphene citrate (Razak Drug Laboratory, Tehran, Iran) for 5 days from the 5th to the 9th day of cycle and highly purified recombinant FSH (Gonal-f, Serono, Hellas, Puregon, Greece) was injected intramuscularly in a dosage of 100 unit/day from the 8th day of the cycle. Then 10000 units of human chorionic gonadotropin (hCG) (Choriomon, IBSA, Switzerland) was injected intramuscularly, if at least one dominant follicles with size of >18mm were seen by transvaginal sonography and serum E2 level was below 2000pg/ml. Intrauterine insemination (IUI) was performed after 36 hours hCG injection. Main outcomes included pregnancy rate, pregnancy rate per cycle, abortion and ongoing pregnancy rates and endometrial thickneness.